the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Qin targets LA 2028 gold after 100m breaststroke world title win

CHINA’s Qin Haiyang has set his sights on Olympic glory at Los Angeles 2028 after reclaiming his 100m breaststroke world title with a thrilling victory over Italy’s Nicolo Martinenghi. Qin clocked 58.23 seconds, edging out Martinenghi (58.58) and Kyrgyzstan’s Denis Petrashov (58.88) in a tightly contested final.

The 26-year-old, who swept all three breaststroke events at the 2023 world championships, rebounded from a disappointing seventh-place finish at the Paris Olympics. “I have a lot of anticipation for LA 2028,“ Qin said. “I’m just getting myself into the frame of mind early. There are still a lot of uncertainties ahead, and I have to be prepared for anything that may come.”

Qin admitted he is still regaining full fitness after injury but called the win a confidence boost. “There are still a few years ahead before the next Olympics, and I want to still be able to achieve my dreams,“ he added.

Martinenghi, the reigning Olympic champion, battled illness to secure silver. “That silver is like a gold for me,“ he said. “I’ve got nothing inside me, I’ve got only my heart and my brain.”

The race was missing Paris Olympic joint silver medallists Adam Peaty and Nic Fink, both of whom skipped the championships. Qin’s preparations for Paris were disrupted by a doping scandal, though he was cleared after WADA accepted China’s explanation of contaminated food. – AFP

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings